Research Article
Predicting Prognosis of Hepatocellular Carcinoma Patients Based on the Expression Signatures of Mitophagy Genes
Table 1
Clinical characteristics of the HCC patients in TCGA and ICGC cohort.
| | Variables | TCGA cohort | ICGC cohort |
| | Cases | 365 | 231 | | Age (median, range) | 61 (16-90) | 69 (31-89) | | Gender (%) | | | | Female | 119 (32.6%) | 61 (26.4) | | Male | 246 (67.4%) | 170 (73.6) | | Grade (%) | | | | G1 | 55 (15.1) | NA | | G2 | 175 (47.9) | NA | | G3 | 118 (32.3) | NA | | G4 | 12 (3.3) | NA | | Unknown | 5 (1.4) | NA | | Stage (%) | | | | I | 170 (46.6) | 36 (15.6) | | II | 84 (23.0) | 105 (45.5) | | III | 83 (22.7) | 71 (30.7) | | IV | 4 (1.1) | 19 (8.2) | | Unknown | 24 (6.6) | 0 (0.0) | | Survival status | | | | OS days (median) | 596 | 780 | | Alive | 235 (64.4) | 189 (81.8) | | Dead | 130 (35.6) | 42 (18.2) |
|
|
HCC: hepatocellular carcinoma; ICGC: International Cancer Genome Consortium; TCGA: The Cancer Genome Atlas.
|
